Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

NewGen’s ordinary shares to begin trading on a split-adjusted basis on February 11, 2025

The technology, which will be acquired for US$5 million, allows for the separation of X and Y chromosome-bearing sperm cells

NewGenIvf shares are trading lower on Monday after the company announced it received a noncompliance notification from the Nasdaq.

New service will address a significant market opportunity and grant new flexibility to women seeking reproductive flexibility

BANGKOK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQNIVF) (“NewGen” or the “Company”) today announced that both parties involved in the previously announced reverse merger with European Wellness Investment Holdings Limited (“EWIHL”) have appointed legal counsel to prepare the Share Purchase Agreement (the “SPA”). Additionally, by mutual consent, the signing date for the SPA has been extended from January 27, 2025, to February 28, 2025. This extension will allow both parties sufficient time to complete the necessary due diligence, finalize the terms of the agreement, and ensure compliance with all relevant NASDAQ requirements for reverse mergers.

NewGen has deployed US$1 million to execute the purchase of its carefully planned digital asset portfolio

The Search Is Over: NewGenIVF Inks Reverse Merger Agreement With European Wellness Investment Holdings

NewGenIvf Group surged premarket after signing a binding term sheet for a reverse merger with European Wellness Investment Holdings.

US$452 million transaction at deemed price of US$3.20 per NewGen share

Multiple strategic initiatives include applying to transfer to Nasdaq Capital Market, leveraging recent fundraising arrangements to boost equity

NewGenIvf Group has inked a binding term sheet with White Lion Capital for a $100M equity line (expandable to $500M), allowing for potential strategic acquisitions and addressing previous noncompliance with Nasdaq.

BANGKOK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQNIVF) (“NewGen” or the “Company”), today announced that it has entered into a binding term sheet (the “Term Sheet”) with White Lion Capital, LLC, (“White Lion”) a California-based institutional investor focused on high-growth, early-stage public companies, setting out the principal terms and conditions for a $100 million equity line of credit, expandable to $500 million.

The biotech world is buzzing as Bright Minds Biosciences (NASDAQDRUG) exploded yesterday with a +1500% surge, rocketing from $2.47 to $38.35 during regular trading, and hitting $50 in after-hours trading—marking a total rise of 1800% in a single day. With its market cap soaring from $4 million to $172 million, this dramatic short squeeze has caught the attention of investors everywhere. Bright Minds, a cutting-edge biotechnology company, is pioneering treatments for neurological and psychiatric disorders, including epilepsy and depression , with its innovative pipeline of selective serotonergic agonists aimed at transforming patient care. DRUG was featured in our pre-market spotlight on 10/15/2024 at just $2.47 per share see more.